Acuta Capital Partners’s Travere Therapeutics TVTX Stock Holding History

Acuta Capital Partners’s Portfolio TVTX Stock Details TVTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$266K	Buy
2016 Q3	–	Sell
2016 Q2	$1.76M	Sell
2016 Q1	$2.73M	Sell
2015 Q4	$7.14M	Buy